Show Summary Details
Page of

The effect of treatment on cognitive deficits in major depressive disorder 

The effect of treatment on cognitive deficits in major depressive disorder
Chapter:
The effect of treatment on cognitive deficits in major depressive disorder
Author(s):

Roger S. McIntyre

, Danielle S. Cha

, and Joanna K. Soczynska

DOI:
10.1093/med/9780199688807.003.0009
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 10 December 2019

Antidepressant pharmacotherapy exerts pro-cognitive effects in MDD, with no compelling evidence that any class antidepressants is more superior over another.

Non-ECT neurostimulatory approaches are associated with less cognitive impairment, and some lines of evidence to suggest indicate that in some MDD subpopulations these neurostimulatory approaches may benefit neurocognition.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.